Back to top
more

Bruker (BRKR)

(Delayed Data from NSDQ)

$63.54 USD

63.54
1,595,375

-2.34 (-3.55%)

Updated Aug 5, 2024 04:00 PM ET

After-Market: $63.56 +0.02 (0.03%) 5:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (103 out of 251)

Industry: Instruments - Scientific

Better trading starts here.

Zacks News

Does Bruker (BRKR) Have the Potential to Rally 33% as Wall Street Analysts Expect?

The consensus price target hints at a 33.5% upside potential for Bruker (BRKR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Bruker (BRKR) to Improve Spatial Biology With New Launch

Bruker's (BRKR) acquired company, Canopy Biosciences, introduced its next generation of ChipCytometry instrumentation for spatial biology.

Bruker (BRKR), Newomics to Co-Market Joint MnESI-MS Platform

The maxis II and timsTOF Pro 2 mass spectrometers from Bruker (BRKR) will be marketed with Newomics's MnESI product line.

Here's Why You Should Invest In Bruker (BRKR) Stock Now

Investors are optimistic about Bruker's (BRKR) better-than-expected revenues and robust segmental performance.

Here's How Much a $1000 Investment in Bruker Made 10 Years Ago Would Be Worth Today

Holding on to popular or trending stocks for the long-term can make your portfolio a winner.

Wall Street Analysts See a 31% Upside in Bruker (BRKR): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 31.4% in Bruker (BRKR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Industry Outlook Highlights: Mettler-Toledo International and Bruker

Mettler-Toledo International and Bruker are highlighted in this Industry Outlook article.

Aniruddha Ganguly headshot

2 Stocks to Buy on Rising Demand for Scientific Instruments

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand as well as rising healthcare spending.

Bruker (BRKR) Q4 Earnings Meet Estimates, Revenues Surpass

Robust performance by the BSI and BEST segments drove Bruker's (BRKR) fourth-quarter top line.

Mettler-Toledo (MTD) Q4 Earnings & Sales Beat, Increase Y/Y

Mettler-Toledo's (MTD) fourth-quarter 2021 results benefit from robust Laboratory and Industrial segments.

Bruker (BRKR) Meets Q4 Earnings Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 0% and 2.83%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Mettler-Toledo (MTD) Q4 Earnings and Revenues Top Estimates

Mettler-Toledo (MTD) delivered earnings and revenue surprises of 4.57% and 1.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Advanced Energy (AEIS) Q4 Earnings Beat, Revenues Rise Y/Y

Advanced Energy's (AEIS) fourth-quarter results reflect strong momentum across semiconductor equipment, data center computing, and industrial and medical markets.

Trimble (TRMB) Q4 Earnings and Revenues Outpace Estimates

Trimble (TRMB) reports strong fourth-quarter results driven by solid momentum across buildings & infrastructure, geospatial, and resources & utilities segments.

Vishay (VSH) Q4 Earnings In Line, Revenues Beat Estimates

Vishay's (VSH) fourth-quarter results benefit from strong momentum across resistor, capacitor, inductor, MOSFET, diode and opto product lines.

Jack Henry (JKHY) Q2 Earnings & Revenues Beat, Rise Y/Y

Jack Henry's (JKHY) second-quarter fiscal 2022 results benefit from strength across Core, Complementary, Corporate and Payments segments.

Carrier (CARR) Q4 Earnings & Sales Beat Estimates, Rise Y/Y

Carrier's (CARR) fourth-quarter results benefit from solid momentum across HVAC, transport refrigeration, and Fire and Security.

Teradata (TDC) Q4 Earnings Beat Estimates, Revenues Down Y/Y

Teradata's (TDC) fourth-quarter 2021 results benefit from customers' migration to Vantage in the cloud. Yet, a decline in perpetual and consulting revenues remains a headwind.

Bruker (BRKR) Earnings Expected to Grow: Should You Buy?

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AMETEK (AME) Q4 Earnings & Sales Beat Estimates, Rise Y/Y

AMETEK's (AME) fourth-quarter results reflect solid momentum in the EIG and EMG segments.

FormFactor (FORM) Q4 Earnings Beat, Revenues Increase Y/Y

FormFactor's (FORM) fourth-quarter 2021 earnings are driven by strong demand for DRAM, Flash and Systems.

PerkinElmer (PKI) Q4 Earnings and Revenues Surpass Estimates

PerkinElmer (PKI) delivered earnings and revenue surprises of 19.07% and 9.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Hold on to Bruker (BRKR) Stock for Now

Investors are optimistic about Bruker's (BRKR) growth in the BioSpin Group and CALID Group.

Is Axcelis Technologies (ACLS) Stock Outpacing Its Computer and Technology Peers This Year?

Here is how Axcelis Technologies (ACLS) and Bruker (BRKR) have performed compared to their sector so far this year.

Bruker (BRKR) Introduces JPK NanoWizard V for AFM Research

Bruker's (BRKR) newly-introduced JPK NanoWizard V is expected to significantly contribute to life science atomic force microscopy investigations.